The Latin America, Middle East and Africa BNP and NT-proBNP Market would witness market growth of 17.9% CAGR during the forecast period (2022-2028).
BNP & NTproBNP measurements can be employed to track the development of the condition and foretell hospitalization risk in people with heart failure. Testing for BNP & NTproBNP is a crucial tool in evaluating and treating many heart disorders. Due to a sizable population of customers who are concerned about their health, the medical device sector is growing and innovating to produce sophisticated diagnostic and biomarker tests, which presents a chance for the BNP & NTproBNP market analysis.
Inactivity, bad eating habits, increased tobacco use, and rising cigarette usage among young people have all increased the risk of strokes, heart attacks, and other CVD issues. As a result, it is primarily responsible for the worldwide disease burden in low- and middle-income nations. Additionally, the increasing use of point-of-care assays, which have advantages over traditional laboratory tests like remote monitoring, shorter hospital stays, higher user experience & patient satisfaction, easier sample collection, and higher accuracy, has a positive impact on the market's expansion.
Furthermore, due to the benefits of high precision and accuracy, minimal pain, and quick diagnosis compared to conventional methods, non-invasive diagnostic procedures are becoming increasingly popular among clinicians. Also driving the market growth are rising government initiatives to expand the accessibility of telemedicine, point-of-care testing, and leading market players concentrating on creating technologically cutting-edge point-of-care testing solutions for cardiovascular diseases.
The majority of countries in the Arabian Middle East are struggling greatly with coronary heart disease (CHD). For instance, in Iraq, Jordan, as well as Syria, CHD is the primary underlying problem of all fatalities. In addition, a high frequency of cardiometabolic risk markers, a lack of patience as well as physician education, infrastructure, and financial constraints lead to a chain of cardiorenal complications (CRCs) occurring at a noticeably younger age. Over the past ten years, the healthcare industry has become one of the GCC's most significant sectors for encouraging economic diversification. This supports the growth of the regional market
The Brazil market dominated the LAMEA BNP and NT-proBNP Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $47.4 Million by 2028. The Argentina market is exhibiting a CAGR of 18.5% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 17.5% during (2022 - 2028).
Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. Based on Application, the market is segmented into Myocardial Infarction, Acute Coronary Syndrome (ACS), Congestive Heart Failure (CHF) and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide BNP and NT-proBNP Market is Projected to reach USD 2.2 Billion by 2028, at a CAGR of 11.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Siemens AG, Danaher Corporation, Gentian Diagnostics ASA, PerkinElmer, Inc., BioMérieux S.A., Quidel Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd. (Roche Holding Ltd.), and Scripps Laboratories.
Scope of the Study
Market Segments Covered in the Report:
By Location of Testing
- Point of Care Testing
- Laboratory Testing
By Application
- Myocardial Infarction
- Acute Coronary Syndrome (ACS)
- Congestive Heart Failure (CHF)
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Siemens AG
- Danaher Corporation
- Gentian Diagnostics ASA
- PerkinElmer, Inc.
- BioMérieux S.A.
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
- F.Hoffmann-La Roche Ltd. (Roche Holding Ltd.)
- Scripps Laboratories
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA BNP and NT-proBNP Market, by Location of Testing
1.4.2 LAMEA BNP and NT-proBNP Market, by Application
1.4.3 LAMEA BNP and NT-proBNP Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA BNP and NT-proBNP Market by Location of Testing
3.1 LAMEA Point of Care Testing Market by Country
3.2 LAMEA Laboratory Testing Market by Country
Chapter 4. LAMEA BNP and NT-proBNP Market by Application
4.1 LAMEA Myocardial Infarction Market by Country
4.2 LAMEA Acute Coronary Syndrome (ACS) Market by Country
4.3 LAMEA Congestive Heart Failure (CHF) Market by Country
4.4 LAMEA Others Market by Country
Chapter 5. LAMEA BNP and NT-proBNP Market by Country
5.1 Brazil BNP and NT-proBNP Market
5.1.1 Brazil BNP and NT-proBNP Market by Location of Testing
5.1.2 Brazil BNP and NT-proBNP Market by Application
5.2 Argentina BNP and NT-proBNP Market
5.2.1 Argentina BNP and NT-proBNP Market by Location of Testing
5.2.2 Argentina BNP and NT-proBNP Market by Application
5.3 UAE BNP and NT-proBNP Market
5.3.1 UAE BNP and NT-proBNP Market by Location of Testing
5.3.2 UAE BNP and NT-proBNP Market by Application
5.4 Saudi Arabia BNP and NT-proBNP Market
5.4.1 Saudi Arabia BNP and NT-proBNP Market by Location of Testing
5.4.2 Saudi Arabia BNP and NT-proBNP Market by Application
5.5 South Africa BNP and NT-proBNP Market
5.5.1 South Africa BNP and NT-proBNP Market by Location of Testing
5.5.2 South Africa BNP and NT-proBNP Market by Application
5.6 Nigeria BNP and NT-proBNP Market
5.6.1 Nigeria BNP and NT-proBNP Market by Location of Testing
5.6.2 Nigeria BNP and NT-proBNP Market by Application
5.7 Rest of LAMEA BNP and NT-proBNP Market
5.7.1 Rest of LAMEA BNP and NT-proBNP Market by Location of Testing
5.7.2 Rest of LAMEA BNP and NT-proBNP Market by Application
Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.2 Siemens AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 SWOT Analysis
6.3 Danaher Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Gentian Diagnostics ASA
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.5 PerkinElmer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 BioMérieux S.A.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Quidel Corporation
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Bio-Rad laboratories, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.9 F. Hoffmann-La Roche Ltd. (Roche Holding Ltd.)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.10. Scripps Laboratories
6.10.1 Company Overview
TABLE 1 LAMEA BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 2 LAMEA BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 3 LAMEA BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 4 LAMEA BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 5 LAMEA Point of Care Testing Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Point of Care Testing Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Laboratory Testing Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Laboratory Testing Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 10 LAMEA BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 11 LAMEA Myocardial Infarction Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Myocardial Infarction Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Acute Coronary Syndrome (ACS) Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Acute Coronary Syndrome (ACS) Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Congestive Heart Failure (CHF) Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Congestive Heart Failure (CHF) Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA BNP and NT-proBNP Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA BNP and NT-proBNP Market by Country, 2022 - 2028, USD Million
TABLE 21 Brazil BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 22 Brazil BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 23 Brazil BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 24 Brazil BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 25 Brazil BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 26 Brazil BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 27 Argentina BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 28 Argentina BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 29 Argentina BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 30 Argentina BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 31 Argentina BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 32 Argentina BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 33 UAE BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 34 UAE BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 35 UAE BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 36 UAE BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 37 UAE BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 38 UAE BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 39 Saudi Arabia BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 40 Saudi Arabia BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 41 Saudi Arabia BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 42 Saudi Arabia BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 43 Saudi Arabia BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 44 Saudi Arabia BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 45 South Africa BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 46 South Africa BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 47 South Africa BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 48 South Africa BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 49 South Africa BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 50 South Africa BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 51 Nigeria BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 52 Nigeria BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 53 Nigeria BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 54 Nigeria BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 55 Nigeria BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 56 Nigeria BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 57 Rest of LAMEA BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 58 Rest of LAMEA BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 59 Rest of LAMEA BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 60 Rest of LAMEA BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 61 Rest of LAMEA BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 62 Rest of LAMEA BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 63 Key Information – Abbott Laboratories
TABLE 64 Key Information – Siemens AG
TABLE 65 Key Information – Danaher Corporation
TABLE 66 Key Information – Gentian Diagnostics ASA
TABLE 67 key Information – PerkinElmer, Inc.
TABLE 68 Key information – BioMérieux S.A.
TABLE 69 key information – Quidel Corporation
TABLE 70 Key Information – Bio-Rad Laboratories, Inc.
TABLE 71 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 72 Key Information – Scripps Laboratories
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories
FIG 3 Swot analysis: Siemens AG